Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,706 GBX | +0.05% | +2.04% | +17.78% |
08:11am | GSK : Sell rating from JP Morgan | ZD |
02:17am | U.S. FDA approves Akebia's anemia drug | RE |
Evolution of the average Target Price on GSK plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering GSK plc
UBS | |
JEFFERIES | Peter Welford |
JPMORGAN | James Gordon |
Guggenheim | |
BERENBERG | Luisa Hector |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
Citigroup | |
Jefferies & Co. | |
Deutsche Bank Securities | |
alphavalue | Abhishek Raval |
DZ BANK | Elmar Kraus |
BARCLAYS | Emily Field |
Morgan Stanley | |
Berenberg Bank | |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
GOLDMAN SACHS | Keyur Parekh |
Bank of America Securities/Merrill Lynch | |
Stifel Nicolaus | |
ODDO BHF | |
Societe Generale | |
Liberum Capital | |
J.P. Morgan Chase | |
DEUTSCHE BANK | Emmanuel Papadakis |
KEPLER CHEUVREUX | David Evans |
BAADER BANK | |
SVB Leerink | |
LBBW | |
BANK OF AMERICA (BOFA) | Graham Parry |
EPS Revisions
- Stock
- Equities
- Stock GSK plc - London S.E.
- Consensus GSK plc